Experimental Pharmacology & Oncology Berlin-Buch's Corporate Minority Round

Experimental Pharmacology & Oncology Berlin-Buch raised a round of funding on September 05, 2018. Investors include CiToxLAB.

Experimental Pharmacology & Oncology Berlin-Buch offers experimental pathology and histopathology services It provides in vitro and in vivo testing of drug candidates with antitumoral and/or immunost…

Articles about Experimental Pharmacology & Oncology Berlin-Buch's Corporate Minority Round: